- This topic has 6 replies, 6 voices, and was last updated 8 years, 9 months ago by
.
-
Very well written and argued.
It will be interesting to see how vested interest groups will try to manipulate, or refute, the data presented in the article, when critiquing it, or attempting to mount a counter argument to justify the status quo. It’s going to take a very skilled spin doctor to do so. The spin, however, will be predicable … there’s only so many ways you can lie about the same thing over and over ….
1983: Hospitalised with Acute non-A, non-B Hepatitis after ICU blood transfusion 3mths earlier => HCV GT2
22/02/16: (pre-tmt) ALT 61, VL 2.48 IU/ml Hepascore 0.32 (F1/2), fatigue, brain fog, bloating (Treatment Naïve)
10/04/16: (Start tmt) Sofovir +DaclaHep (SOF + DCV) by Hetero Labs in India
09/05/16: ALT 34, VL: NOT Detected
🙂 , FBG 11.9 
17/6/16 FBG 5.7; PPBG (@14.22) 6.9 (@ 20.45) 7.1; BP 124/72
🙂 (Accu-Chek Mobile & Omron Auto BP Monitor) 🙂Congratulations
. Who knew a medical journal article could be such a gratifying read.
Thank you Dr. Freeman, for this addition to our ever growing arsenal of weapons we can utilize in this fight against the enemies weapons of choice. That is, ignorance and deliberate misinformation, aimed at FixhepC and generic efficacy.
Excuse me for using the wartime analogies, but for most of us here, we are truly in a fight for our lives and this seems apropos.
MK
(Please consider this message as a kind of fun/joke/crazy idea):
Thinking on the compare made in the article about producing the wine, I was getting amuzed by the idea of how would it be if one could make at home his/her own Sovaldi or Harvoni
?
That would be a nice dream for HCV patients, perhaps a nightmare for Gilead.(I end this message with ” Do not try this at home”
Cheers
RHF
- You must be logged in to reply to this topic.